Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2019-03-04
Buyer: DHL Supply Chain Limited acting on behalf of Supply Chain Coordination Ltd acting as agent of the NHS Business Services Authority
Country: UK
Contract type: Supplies
CPV classification: 33140000: Medical consumables | 33141600 | 33194000
Estimated value: 32000000 GBP

Technical requirements: Non-exclusive Framework Agreement for the supply to the NHS Supply Chain customer base via the non-direct routes of stock, blue diamond and e-direct. Product range to include, but not limited to:
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 8 000 000 GBP in the first year of this Framework Agreement, however this is approximate only and may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
NHS Supply Chain is currently considering the use of lots for this procurement. However, it reserves the right not to as part of any future tender process. Further information in respect of the lot strategy will be set out in the notice for the forthcoming procurement.
Products that are within scope of this lot shall include, but shall not be limited to, products used in connection with the following types of products and systems:
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 2 600 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
This lot includes, but is not limited to, all post-operative autologous (otherwise known as transfusion or auto-transfusion) blood system products, including such as kits and consumable products. These products provide safe post-operative drainage and reinfusion capabilities in one system. A post-operative autologous blood system is for recovering blood from a wound site after certain types of surgery e.g. orthopedic surgery including total knee and total hip replacements. The range of products that may be supplied under this lot includes all products that are used in connection with this type of post-operative medical procedure.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 900 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
The requirement is for intra-operative autologous blood system products used in the medical procedure that involves recovering blood lost during surgery and re-infusing blood, or blood products, into the patient. The range of products that can be supplied under this lot includes all products that are used in connection with this type of procedure including, but not limited to, intra-operative machines, collection reservoirs, reservoir holders, collection sets, aspiration and anti-coagulation lines, suction tips and tubing, waste bags, re-infusion bags, auto transfusion kits and wash sets.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 500 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
The lot requirements are for lease agreements of the intra-operative autologous blood system capital systems with leasing costs tied into the set usage of intra-operative autologous blood system capital equipment associated consumables.
The requirement is for intra-operative autologous blood system products used in the medical procedure that involves recovering blood lost during surgery and re-infusing blood, or blood products, into the patient. The range of products that can be supplied under this lot includes all products that are used in connection with this type of procedure including, but not limited to, intra-operative machines, collection reservoirs, reservoir holders, collection sets, aspiration and anti-coagulation lines, suction tips and tubing, waste bags, re-infusion bags, auto transfusion kits and wash sets.
Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of 4 000 000 GBP in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement.
The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time.
The following certification will be a requirement of the upcoming tender exercise and applicants may be required to include evidence of this with their tender submission:
— ISO 9001:2015 or equivalent externally accredited and up-to-date quality standard certificate(s) to cover all segments of the applicant's (and the product's) supply chain. This should include but not be limited to manufacturing storage and distribution. Further information in respect of certification requirements will be set out in the notice for the forthcoming procurement. If such certificates are not in the name of the applicant then the applicant must supply a copy of agreements setting out the authority and responsibilities of all parties in the supply chain,


Award value: 32000000